fragment 176-191 & mod grf 1-29 & ipamorelin blend - 12MG Frag 176-191 & Mod GRF

IGF-1 LR3 Trials: IGF-1 LR3 itself is not FDA-approved for any human use

Label and Store: If it's not already dated, label your vial with the date of reconstitution and the final concentration (e.g., 'Retatrutide 5mg/mL 10/26/23')

PMID: 36682385

Bala CG, Rusu A, Ciobanu D, Bucsa C, Roman G

Importantly, these effects occur without activation of growth hormone receptor pathways or alteration of IGF-1 signaling, allowing AOD 9604 to be used as a tool for isolating metabolic signaling mechanisms

The formulation also provides antifibrotic benefits, helping to prevent excessive fibroblast proliferation and scar formation